• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双膦酸盐对前列腺癌骨转移进展的延缓作用。

Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates.

作者信息

Sun Y C, Geldof A A, Newling D W, Rao B R

机构信息

Department of Endocrinology, Academisch Ziekenhuis Vrije Universiteit, Amsterdam, The Netherlands.

出版信息

J Urol. 1992 Oct;148(4):1270-3. doi: 10.1016/s0022-5347(17)36890-8.

DOI:10.1016/s0022-5347(17)36890-8
PMID:1404658
Abstract

Prostate tumor cell metastasis to the axial skeleton was induced in male Copenhagen rats using the intravenous injection of syngeneic metastatic R3327-MATLyLu tumor cells and concomitant caval vein clamping. The proliferation of tumor cells in the lumbar region was monitored by the progression, within 19 days post tumor cell injection, of hindleg paralysis which appeared in these animals. Histology confirmed the presence of tumor cells within the lumbar spine in 100% of cases displaying hindleg paralysis. Treatment with either of the bisphosphonate drugs, Cl2MDP or APD, suppressed and delayed the development of hind leg paralysis. Bisphosphonate treatment may be expected to delay the onset of axial skeletal metastasis effects in prostate cancer patients.

摘要

通过静脉注射同基因转移性R3327-MATLyLu肿瘤细胞并同时钳夹腔静脉,在雄性哥本哈根大鼠中诱导前列腺肿瘤细胞转移至中轴骨骼。在肿瘤细胞注射后19天内,通过这些动物出现的后肢麻痹进展来监测腰区肿瘤细胞的增殖。组织学证实,在100%出现后肢麻痹的病例中,腰椎内存在肿瘤细胞。使用双膦酸盐药物Cl2MDP或APD进行治疗可抑制并延缓后肢麻痹的发展。双膦酸盐治疗有望延缓前列腺癌患者中轴骨转移效应的发生。

相似文献

1
Progression delay of prostate tumor skeletal metastasis effects by bisphosphonates.双膦酸盐对前列腺癌骨转移进展的延缓作用。
J Urol. 1992 Oct;148(4):1270-3. doi: 10.1016/s0022-5347(17)36890-8.
2
Prostatic tumor (R3327) skeletal metastasis.前列腺肿瘤(R3327)骨转移。
Prostate. 1990;16(4):279-90. doi: 10.1002/pros.2990160402.
3
The use of bisphosphonates in prostatic cancer.
Clin Oncol (R Coll Radiol). 1994;6(2):77-8. doi: 10.1016/s0936-6555(05)80107-4.
4
Radionuclide therapy for prostate cancer lumbar metastasis prolongs symptom-free survival in a rat model.
Urology. 1997 May;49(5):795-801. doi: 10.1016/S0090-4295(96)00576-6.
5
Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results.激素难治性前列腺癌患者尸检时的骨组织学及匹配的骨闪烁显像结果:双膦酸盐治疗对骨闪烁显像结果的影响
Clin Exp Metastasis. 2003;20(2):171-80. doi: 10.1023/a:1022627421000.
6
Oral bisphosphonates: A review of clinical use in patients with bone metastases.口服双膦酸盐:骨转移患者临床应用综述
Cancer. 2000 Jan 1;88(1):6-14.
7
Factors in prostate cancer metastasis.前列腺癌转移的相关因素。
Anticancer Res. 1990 Sep-Oct;10(5A):1303-6.
8
Bisphosphonates in prostate carcinoma.双膦酸盐在前列腺癌中的应用。
Cancer. 1997 Oct 15;80(8 Suppl):1674-9. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1674::aid-cncr18>3.3.co;2-d.
9
[Bisphosphonates and bone metastases].[双膦酸盐与骨转移]
Bull Cancer. 1999 Sep;86(9):732-8.
10
Bisphosphonates and breast carcinoma.双膦酸盐与乳腺癌
Cancer. 1997 Oct 15;80(8 Suppl):1668-73. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1668::aid-cncr17>3.3.co;2-5.

引用本文的文献

1
Rat models of bone metastases.骨转移的大鼠模型
Clin Exp Metastasis. 2005;22(8):605-14. doi: 10.1007/s10585-006-9002-5. Epub 2006 May 3.
2
Utility of bisphosphonates in treating bone metastases.
Med Oncol. 1996 Dec;13(4):215-21. doi: 10.1007/BF02990934.